WebDisclosure WebDisclosure
Basculer en Français
9903 Companies
199502 Keywords
130356 Articles
106024 Press releases
Headlines Articles Press releases Aytu BioPharma, Inc. Remove
  1. Home
  2. Companies
  3. Aytu BioPharma, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/05/2025 at 23:55, 1 year ago

    Aytu BioPharma to Announce Q2 2025 Financial Results

    Financial Results Conference Call Pharmaceuticals Webcast Aytu BioPharma
  • BRIEF

    published on 02/05/2025 at 23:55, 1 year ago

    Aytu BioPharma annoncera ses résultats financiers du deuxième trimestre 2025

    Résultats Financiers Webcast Conférence Téléphonique Médicaments Aytu BioPharma
  • PRESS RELEASE

    published on 02/05/2025 at 23:50, 1 year ago

    Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

    Aytu BioPharma, Inc. to report Q2 fiscal 2025 results on Feb 12, 2025. Conference call and webcast scheduled for investors and analysts
    Financial Results Conference Call Webcast Q2 Fiscal 2025 Aytu BioPharma
    Logo of Aytu BioPharma, Inc.
Accesswire
  • Published on 02/20/2026 at 15:45, 1 hour 28 minutes ago

    Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway

  • Published on 02/20/2026 at 14:30, 2 hours 43 minutes ago

    Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant

  • Published on 02/20/2026 at 14:08, 3 hours 5 minutes ago

    Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange

  • Published on 02/20/2026 at 14:00, 3 hours 13 minutes ago

    Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

  • Published on 02/20/2026 at 13:30, 3 hours 43 minutes ago

    ESGold Launches 70 km2 District-Scale ANT Survey at Montauban Following 3D Model Identifying Deep, Expanding 2 km Mineralized Corridor

View all ACCESSWIRE
EQS Group
  • Published on 02/20/2026 at 17:05, 8 minutes ago

    Eurobattery Minerals publishes its year-end report for 2025 while working on design & construction of the tungsten processing plant at San Juan

  • Published on 02/20/2026 at 16:38, 34 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 02/20/2026 at 15:25, 1 hour 48 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: JTC plc

  • Published on 02/20/2026 at 15:24, 1 hour 49 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Beazley plc

  • Published on 02/20/2026 at 15:23, 1 hour 49 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS
Les Echos
  • Published on 02/20/2026 at 09:28, 7 hours 45 minutes ago

    Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026

  • Published on 02/20/2026 at 09:28, 7 hours 45 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

  • Published on 02/20/2026 at 07:30, 9 hours 43 minutes ago

    Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan

  • Published on 02/20/2026 at 07:30, 9 hours 43 minutes ago

    Announcement of share buyback in the context of a share purchase plan

  • Published on 02/20/2026 at 07:30, 9 hours 43 minutes ago

    Announcement of share buyback in the context of a share purchase plan

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy